What are your institutions' preferences on SBRT vs. histotripsy for treatment of liver metastases?
Are you aware of any data to support one modality over the other?
Answer from: Radiation Oncologist at Community Practice
I'll avoid the institutional political discussion of competing modalities. Like many ablative modalities, there is limited data directly comparing the safety and effectiveness of SBRT. As the new kid on the block, histotripsy has no comparative data that I'm aware of with existing modalities.HistoSo...
Comments
Radiation Oncologist at Sarah Cannon Research Institute Well said. Let's hope it doesn't take 4 decades to...
Well said. Let's hope it doesn't take 4 decades to...